Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents

by Fabbri Leonardo M, Tashkin Donald P
Published 2010-10-01

Adverse health consequences in COPD patients with rapid decline in FEV₁- evidence from the UPLIFT trial

by Liu Dacheng, Decramer Marc, Celli Bartolome, Kesten Steven, Tashkin Donald
Published 2011-09-01

Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease

by Celli Bartolome R, Decramer Marc, Lystig Theodore, Kesten Steven, Tashkin Donald P
Published 2012-08-01

Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial

by Decramer Marc, Celli Bartolome, Sharafkhaneh Amir, Hanania Nicola A, Lystig Ted, Kesten Steven, Tashkin Donald
Published 2011-01-01

Comparison of the variability of the annual rates of change in FEV₁ determined from serial measurements of the pre- versus post-bronchodilator FEV₁ over 5 yea...

by Tashkin Donald P, Wang He-Jing, Halpin David, Kleerup Eric C, Connett John, Li Ning, Elashoff Robert
Published 2012-08-01

HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation

by Baay-Guzman Guillermina J, Bebenek Ilona G, Zeidler Michelle, Hernandez-Pando Rogelio, Vega Mario I, Garcia-Zepeda Eduardo A, Antonio-Andres Gabriela, Bonavida Benjamin, Riedl Marc, Kleerup Eric, Tashkin Donald P, Hankinson Oliver, Huerta-Yepez Sara
Published 2012-07-01